TNF and Alzheimer disease: Epidemiological studies indicate that AD is less prevalent in patients on anti‐TNF blockers for rheumatoid arthritis (Chou et al, 2016), but clinical trials using anti‐TNF blockers in AD patients have been inconclusive (Tobinick et al, 2006; Tobinick & Gross, 2008).